Fig. 8. Silencing CDK1 or RhoA could also reverse circ-NOLC1’s function as an oncogene.
Silencing CDK1 or RhoA in circ-NOLC1-overexpressing CAOV3 cells significantly reduced cell viability A, cell migration B, and invasion C ability. CDK1 or RhoA knockdown reduced CDK1 or RhoA protein expression, but not ESRP1 protein expression (D). Results are representative of three separate experiments; data are expressed as the mean ± SD. Comparisons between two groups were analyzed using a two-sided Student’s t test. *p < 0.05.